Summary

Overview
Global Chronic Wound Care market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
A chronic wound is a wound that does not recover in an orderly set of phases and in a predictable amount of period or injuries that do not recover within three months are usually regarded chronic. Chronic wounds usually stay in the inflammatory phase for too long and may never recover or may take years.
Market Dynamics: Drivers & Restraints
Advanced Product Development and New Product Introductions
The advanced product development and new product introductions into the market are expected to boost the global market growth during the forecast period. For instance, in October 2023, Healiva developed EpiDex autologous epidermis patches for the therapy of chronic wounds, based on cells originating from a patient’s hair strands.
Moreover, in October 2022, Healthium Medtech introdined a new wound dressing product line, Theruptor Novo, for the control of chronic wounds such as diabetic foot ulcers and leg ulcers. Additionally, the rise in diabetes ulcer and vascualr ulcer cases cases and growing market developments are among other factors that are expected to contribute to the global market growth during the forecast period.
High Treatment Cost
Nevertheless, the high cost of wound care treatment since the treatment runs for longer duration is hampering the global market growth along with the others factors including stringent regulations for approval from regulatory authorities, high development costs and lack of professionals hampering the global market growth during the forecast period.
Segment Analysis
The global chronic wound care market is segmented based on product type, wound type, end user and region.
Foam Dressing Product Type is Expected to Dominate Market
Foam Dressings are expected to dominate the global market during the forecast period owing to increasing product introductions in the segment. For instance, in June 2022, Medline introduced its OptifoamGentle EX Foam Dressing. When united with a pressure injury prevention protocol, the development is purposed to assist in deposing pressure. Moreover, in May 2022, Winner Medical revealed its latest and industry-leading cutting-edge surgical wound care developments, such as the Transparent Film Dressing, Bordered Silicone Foam Dressing with SAF and Antibiosis Series Products, and the Carboxymethylcellulose (CMC) dressing.
Geographical Analysis
North America is Expected to Dominate the Global Market
Owing to the increasing cases of diabetes, pressure injuries, and the increasing market developments are expected to boost the North America market to dominate the global market during the forecast period. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth Edition, in 2021, about 32.2 million individuals in the United States had diabetes, which is projected to increase to 36.3 million by 2045.
Moreover, according to the National Center for Biotechnology Information report, in December 2021 a significant number of 1.0 to 3.0 million individuals in the U.S. suffered from pressure injuries, emphasizing the requirement for efficacious wound management solutions. Further, in April 2023 Kane Biotech formed a distribution arrangement with ProgenaCare Global for its coactive antimicrobial wound gel to get technology to the wound care and surgical markets in the U.S. with an emphasis on inexpensive and effective wound care technologies.
COVID-19 Impact Analysis
Delayed wound care was of special consideration during the COVID‐19 pandemic. Since they usually have underlying comorbidities like diabetes, chronic wound patients are at improved threat for more threatening COVID‐19 consequences in the duration of hospitalization and death. However, post-pandemic the situation is returning to pre-pandemic conditions.
Market Segmentation
By Product Type
• Advanced Wound Dressing
o Foams Dressings
o Hydrogel Dressings
o Collagen Dressings
o Other Dressings
• Active Wound Care
o Skin-grafts
o Growth Factors
• Therapy Devices
o Negative Pressure Wound Therapy Devices
o Pressure Relief Devices
o Hyperbaric Oxygen Equipment
o Other Devices
By Wound Type
• Diabetic Foot Ulcer
• Pressure Ulcer
• Arterial and Venous Ulcer
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In September 2022, Evonik formed an agreement with the medical technology consulting and sales corporation Coopmed for the distribution of the wound dressing Epicite.
• In September 2023, Healiva formed a strategic collaboration with Lausanne University Hospital (CHUV, ‘Centre Hospitalier Universitaire Vaudois’) for the manufacturing and clearance of its autologous epidermal equivalent, Epidex.
• In July 2022 Smith Nephew introduced its clinical support app WOUND COMPASS. The complete digital asset tool for clinicians in injury review and decision-making to decrease variation in practice.
Competitive Landscape
The major global players in the market include 3M Company, Cardinal Health Inc., Coloplast AS, B. Braun SE, Integra Lifesciences, Smith & Nephew, ConvaTec Group PLC, Mölnlycke Health Care AB, Johnson & Johnson and Medtronic Plc. among others.
Why Purchase the Report?
• To visualize the global chronic wound care market segmentation based on product type, wound type, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of chronic wound care market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global chronic wound care market report would provide approximately 61 tables, 58 figures and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Wound Type
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Advanced Product Development and New Product Introductions
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Treatment Cost
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Pricing Analysis
5.3. Regulatory Analysis
5.4. Patent Analysis
5.5. Technology Trend
5.6. Unmet Need
5.7. Epidemiology Analysis
5.8. SWOT Analysis
5.9. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Advanced Wound Dressing*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Foams Dressings
7.3.1. Hydrogel Dressings
7.3.2. Collagen Dressings
7.3.3. Other Dressings
7.4. Active Wound Care
7.4.1. Skin-grafts
7.4.2. Growth Factors
7.5. Therapy Devices
7.5.1. Negative Pressure Wound Therapy Devices
7.5.2. Pressure Relief Devices
7.5.3. Hyperbaric Oxygen Equipment
7.5.4. Other Devices
8. By Wound Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
8.1.2. Market Attractiveness Index, By Wound Type
8.2. Diabetic Foot Ulcer*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pressure Ulcer
8.4. Arterial and Venous Ulcer
8.5. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Specialty Clinics
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Wound Type
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. 3M Company, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Cardinal Health Inc.
12.3. Coloplast AS, Inc.
12.4. B. Braun SE
12.5. Integra Lifesciences
12.6. Smith & Nephew,
12.7. ConvaTec Group PLC
12.8. Mölnlycke Health Care AB
12.9. Johnson & Johnson
12.10. MEDTRONIC PLC.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us